Bach, M. A., Rockwood, K., Zetterberg, C., Thamsborg, G., Hebert, R., Devogelaer, J. P.
, Christiansen, J. S., Rizzoli, R., Ochsner, J. L., Beisaw, N., Gluck, O., Yu, L., Schwab, T., Farrington, J., Taylor, A. M., Ng, J. & Fuh, V. (2004).
MK 0677 Hip Fracture Study Group. The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture.
J. Am. Geriatr. Soc.,
52(4), 516-523.